Navigation Links
FDA Schedules Third Orphan Drug Workshop for Nov. 4-5, 2010
Date:10/13/2010

SILVER SPRING, Md., Oct. 13 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration has scheduled the third in a series of workshops on orphan drug designation for academics, biotechnology companies, and those unfamiliar with the process for Nov. 4-5, 2010, in Lansdowne, Va.

(Logo:  http://photos.prnewswire.com/prnh/20090824/FDALOGO)

(Logo:  http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO)

The workshop, in collaboration with the Drug Information Association, will focus on the process used by the FDA to grant a special status, known as orphan designation, for drug products intended to treat rare diseases. Similar workshops were held earlier this year in Claremont, Calif., and Minneapolis.

Orphan drugs are either drug or biologic products used to treat diseases or conditions affecting fewer than 200,000 people in the United States. Orphan drug designation is available for drugs already approved for another disease or condition or for experimental drugs that have not been previously approved.

During the workshop, participants will propose a specific drug for a specific rare disease and work on an orphan designation application to submit to the FDA at the conclusion of the workshop. FDA staff will provide one-on-one guidance to help participants develop strong applications.

To obtain orphan drug designation, drugs must be for the treatment, prevention or diagnosis of a rare disease or condition. Designation also requires there be a scientific rationale for expecting the proposed drug to be effective in the treatment, prevention, or diagnosis of that disease or condition.

Orphan designation qualifies the applicant to receive certain benefits, such as tax credits and marketing incentives, from the federal government in exchange for developing the drug. After desi
'/>"/>

SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Varian Medical Systems Schedules Fourth Quarter FY2010 News Release and Conference Call
2. Misonix Schedules Fourth Quarter and Fiscal 2010 Financial Results Conference Call; September 28, 2010 at 4:30 p.m. Eastern
3. Renhuang Schedules Conference Call to Discuss FY 2010 Third Quarter Results
4. Varian Medical Systems Schedules Investor Meeting and Fiscal Year End Review at ASTRO in San Diego, November 2, 2010
5. Sunridge Schedules European Meetings
6. Unilife Corporation Schedules Fiscal 2010 Fourth Quarter and Year End Conference Call for Monday, August 30, 2010
7. WuXi PharmaTech RESCHEDULES Second-Quarter 2010 Earnings Conference Call
8. Orexigen® Therapeutics Schedules August 5, 2010 Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2010
9. VirtualScopics Schedules Second Quarter 2010 Earnings Announcement
10. Thoratec Schedules Second Quarter Conference Call, Webcast
11. Alere Inc. Schedules Conference Call for 10:00 a.m. ET July 28, 2010 to Discuss Second Quarter 2010 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... , May 18, 2013 Faruqi ... firm, is investigating potential securities fraud at AVEO ... (Logo: http://photos.prnewswire.com/prnh/20120119/MM38856LOGO ) ... and its executives violated federal securities laws by ... Company,s Phase III drug trials for Tivopath (tivozanib) ...
(Date:5/17/2013)... SAN DIEGO , May 17, 2013 /PRNewswire/ ... today that its Fast-Track Advanced Technology Small Business ... National Institute of Allergy and Infectious Diseases (NIAID), ... (NIH), supporting the development of novel human antibody ... S. aureus or Staph) infections, including methicillin-resistant ...
(Date:5/17/2013)... 17, 2013  Sony Biotechnology Inc. ("Sony") today announced the ... and 130um sorting chip.  Sony will also be exhibiting its ... SH800 Cell Sorter, the EC800 flow cytometer, and new SP6800 ... 2013, which will be held at the San ... California , from May 20 - 22.  ...
Breaking Medicine Technology:Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 3Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 4Sony Delivers New Technology for Science to CYTO 2013 2
... , DURHAM, N.C., Sept. 8 ... formally notified Vatea Fund of the company,s achievement of a milestone ... September 1, 2009. The milestone is a Clinical Trial for Oxycyte ... With the achievement of the milestone, the agreement calls for ...
... BOZEMAN, Mont., Sept 8 LigoCyte Pharmaceuticals, Inc. ... clinical trial of its norovirus vaccine. The Phase I/II ... nasally-delivered, dry powder vaccine in healthy adults. The study will ... by including a live virus challenge of subjects that have ...
Cached Medicine Technology:LigoCyte Pharmaceuticals Initiates a Randomized, Double Blind, Placebo Controlled Norovirus Vaccine Study Including Live Virus Challenge 2LigoCyte Pharmaceuticals Initiates a Randomized, Double Blind, Placebo Controlled Norovirus Vaccine Study Including Live Virus Challenge 3
(Date:5/20/2013)... CA (PRWEB) May 20, 2013 ... in adult allogeneic stem cell manufacturing, research and ... Professor of Medicine and Director of Interventional Cardiology ... to join the Scientific and Medical Advisory Board ... University of Pennsylvania, Dr. Wilensky divides his time ...
(Date:5/20/2013)... CA (PRWEB) May 20, 2013 This ... around the world will make the pilgrimage to San ... 2nd annual Digital Health Summer Summit produced ... provides a unique forum to showcase the latest digital ... best practices, and network with some of industry’s most ...
(Date:5/20/2013)... May 20, 2013 Adeptia ... and on-premise business process integration solutions, today ... its next-generation integration solution. Version 6.0 ... that seamlessly automates business processes involving data ... meaningful business user interaction for real-time decision-making ...
(Date:5/20/2013)... (HealthDay News) -- Although many hospital intensive care ... to help improve outcomes, new research suggests this ... Since one-third of teaching hospitals in the United ... a nighttime physician in the ICU, the practice ... away from hospitals with fewer resources, the study ...
(Date:5/20/2013)... 2013 In celebration of National Women’s ... accomplishments achieved at The Feinstein Institute for Medical ... Advancing Women in Science and Medicine (AWSM) , ... Scientists, educators, business and community leaders from the ... of women in science. , “Women face unique ...
Breaking Medicine News(10 mins):Health News:Noted Cardiologist Robert Wilensky to Join Stemedica Cardiology Division Scientific & Medical Advisory Board 2Health News:Noted Cardiologist Robert Wilensky to Join Stemedica Cardiology Division Scientific & Medical Advisory Board 3Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 2Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 3Health News:Living in Digital Times Brings Together Leaders in Digital Health for Summer Summit in San Diego 4Health News:Adeptia Announces New Release of Enterprise Business Integration Solution 2Health News:Adeptia Announces New Release of Enterprise Business Integration Solution 3Health News:Nighttime Docs at ICUs Don't Boost Patient Outcomes: Study 2Health News:North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week 2Health News:North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week 3
... Half of alcohol-linked deaths are tied to bouts of excessive ... Binge drinking in the United States is most common among ... make $50,000 or more a year, according to a study ... five or more drinks on one occasion. , The U.S. ...
... that growing mouse skin cells in spheres can lead to ... without genetic manipulation of stem cell genes. This unexpected finding, ... the journal Cell Stem Cell , provides a potential ... and may even eventually lead to safer strategies for creation ...
... among the best bets to reverse a deep recession that ... of books that offer the most comprehensive analysis ever on ... International Gambling Report Series recommends the United States and ... growth and cost taxpayers at least $3 for every $1 ...
... CARY, N.C., April 2 MicroMass Communications, Inc., ... the healthcare industry, has promoted Kim Levy to ... N.J. office, she will continue to provide strategic ... the agency,s business development and marketing efforts. She ...
... MMI Director Nominees Will Bring Much-Needed Independence and ... 2 MMI Investments, L.P. ("MMI") today announced ... newly-elected Chairman of Chemed Corporation ("Chemed"), George J. ... Chemed,s culture of corporate largesse, as embodied in ...
... Awareness Month and offers a challenge to businesses , ... ... Safeway (NYSE:SWY), Easter Seals and Special Olympics launched the ... in Washington, D.C., by challenging employers to tap into what they ...
Cached Medicine News:Health News:Typical Binge Drinker Is Young White Male 2Health News:Cancer stem cells generated by cancer outgrowth 2Health News:New book series renews call for ban on gambling 2Health News:MicroMass Promotes Kim Levy To Senior Vice President 2Health News:Chemed Corporation Purchases a Second Corporate Jet - MMI Investments Demands an End to Chemed Corporate Largesse 2Health News:Chemed Corporation Purchases a Second Corporate Jet - MMI Investments Demands an End to Chemed Corporate Largesse 3Health News:Chemed Corporation Purchases a Second Corporate Jet - MMI Investments Demands an End to Chemed Corporate Largesse 4Health News:Safeway Slated to Top $100 Million Contribution Mark to Easter Seals and Families Living with Autism and Other Disabilities with Launch of Fundraising Campaign 2Health News:Safeway Slated to Top $100 Million Contribution Mark to Easter Seals and Families Living with Autism and Other Disabilities with Launch of Fundraising Campaign 3Health News:Safeway Slated to Top $100 Million Contribution Mark to Easter Seals and Families Living with Autism and Other Disabilities with Launch of Fundraising Campaign 4
Used for drainage and navigation of a tortuous ureter. The tapered tip eases placement as there are no edges to interfere with the ureteral orifice. Supplied sterile in peel-open packages. Intended f...
Used for the retrieval of stones, stents, or other objects in the urinary tract under direct vision. Retrieval Forceps are designed for use through rigid or flexible endoscopes. Supplied sterile in p...
... Angle Cutting Electrode is a monopolar ... general purpose monopolar electrosurgical generator and ... ACMI rigid, semi-rigid, or flexible ureteroscope ... working channel larger than 3 Fr. ...
... The ACMI USA Series ACN-2 Flexible CystoNephroscope ... It is ideal for office practice. The ... accommodates a full range of operating instruments ... outer diameter, and beveled, UltraGlide covered tip ...
Medicine Products: